Earnings Growth Rally May Not Shield Markets From Bear Threat SEBI Cracks Down on Stock Manipulation 7 Entities Barred 20 Crore Gains Frozen Dulux Parent AkzoNobel Stock Surges 21 on Takeover Bid European Markets Rise Amid Iran Tensions SurveyMonkey Report Highlights Potential TradeOffs of AI Adoption in the Workplace The Key Metric in an AI Companys Latest Earnings That Could Shift Investor Sentiment National Retail Federation Projects 44 Growth in US Retail Sales for 2026 Senti Biosciences Inc Q1 2026 Earnings Narrowing Losses and Gene Circuitry Progress Astera Labs Inc ALAB Q1 2026 Earnings EPS Surpasses Estimates as Shares Climb Nordson NDSN Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower SELLAS Life Sciences Group SLS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Progress MasTec MTZ Q1 2026 Earnings Strong EPS Beat Drives Optimism Despite Stock Dip Transdigm Group TDG Q1 2026 Earnings EPS Surpasses Estimates as Core Markets Remain Strong HCICU Holds Steady at 1004 A SPAC Unit Showing Stability Amid Market Uncertainty ATS Corporation ATS Surges 267 as Stock Tests Resistance Near 3740 Church Dwight CHD Holds Steady with Modest Gains as Defensive Appeal Endures Allspring Income Opportunities Fund EAD Edges Higher on Modest Gains Uxin Limited UXIN Stabilizes at 236 After Modest Gain Key Levels in Focus US Battery Module Manufacturing Capacity Sufficient for Domestic Demand ACP Claims SILO Q4 2023 Earnings EPS Misses Estimates as Biotech Firm Reports Wider Than Expected Loss Viking Holdings VIK Surges 42 to 9143 Testing Key Resistance Levels Royal Observatory Warns Against AI Dependency Raises Questions on Human Value in TechDriven Economy Coastal Fin CCB Up 244 Is There More Room to Run 20260520 INLIF INLF Down 129 Is the SellOff Overdone 20260521 Allarity ALLR Posts Q1 2026 Earnings Beat Heres What Drove It China Chides US After Trump Says He Will Talk to Taiwans Lai IRIDEX Corporation Reports First Quarter 2026 Results Key Takeaways from Earnings Call Propanc Biopharma PPCB Earnings Outlook Key Metrics for Q3 2025